Fenfluramine increases survival and reduces markers of neurodegeneration in a mouse model of Dravet...
Fenfluramine increases survival and reduces markers of neurodegeneration in a mouse model of Dravet syndrome
About this item
Full title
Author / Creator
Publisher
United States: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
United States: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Dravet syndrome is a severe epilepsy disorder that impairs learning and causes premature death. Clinical studies in patients with Dravet syndrome show that fenfluramine reduces convulsive seizures. Additional studies suggest that fenfluramine may have benefits beyond seizures, including promoting survival and improving control over emotions and beh...
Alternative Titles
Full title
Fenfluramine increases survival and reduces markers of neurodegeneration in a mouse model of Dravet syndrome
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_2b6507ecce2d48699f0a03d19bb7e3d3
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_2b6507ecce2d48699f0a03d19bb7e3d3
Other Identifiers
ISSN
2470-9239
E-ISSN
2470-9239
DOI
10.1002/epi4.12873
